Senior insider sale
Chief Executive Officer at AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$33.48M
144.34K shares
What this filing means
TABUTEAU HERRIOT plans to sell 144.34K shares of AXSOME THERAPEUTICS, INC. valued at approximately $33.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/5/2026ACC: 0001958244-26-000488
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
144.34K
Shares to sell
$33.48M
Approx. market value
45K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
3/15/2017
45KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2017 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 45K | — |
| Total | 45K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
24.83K
Market value
$6.00M
7/1/2026
—Completed
Units to sell
24.83K
Market value
$5.93M
7/1/2026
—Completed
Units to sell
24.84K
Market value
$5.95M
6/9/2026
—Completed
Units to sell
24.84K
Market value
$6.02M
6/9/2026
Planned — Approximate Date
NASDPlanned
Units to sell
45K
Market value
$9.58M
8/5/2026
Total
Units
144.34K
Value
$33.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 24.83K | $6.00M | — | Completed |
7/1/2026 | 24.83K | $5.93M | — | Completed |
6/9/2026 | 24.84K | $5.95M | — | Completed |
6/9/2026 | 24.84K | $6.02M | — | Completed |
| Planned — Approximate Date | ||||
8/5/2026 | 45K | $9.58M | NASD | Planned |
| Total | 144.34K | $33.48M | ||